Specific suppression of antibody rebound after extracorporeal immunoadsorption. I. Comparison of single versus combination chemotherapeutic agents.
D000818:Animals; D000915:Antibody Affinity; D000917:Antibody Formation / Q000187:drug effects*; D003520:Cyclophosphamide / Q000494:pharmacology; D003561:Cytarabine / Q000494:pharmacology; D004285:Dogs; D004359:Drug Therapy, Combination; D007163:Immunosorbent Techniques; D007165:Immunosuppression Therapy; D008727:Methotrexate / Q000494:pharmacology; D012709:Serum Albumin / Q000276:immunology; D012710:Serum Albumin, Bovine / Q000276:immunology
D012709:Serum Albumin; D003561:Cytarabine; D012710:Serum Albumin, Bovine; D003520:Cyclophosphamide; D008727:Methotrexate